Fuso Pharmaceutical Industries (TSE:4538) ROCE %: 7.92% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4538 Fuso Pharmaceutical Industries Ltd TSE:4538
51 GF Score
Price 円2,140.00
GF Value 円2,553.90
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Fuso Pharmaceutical Industries ROCE %?

Fuso Pharmaceutical Industries TSE:4538 -0.74% 51 ROCE % is 7.92% as of Mar. 2026. GuruFocus rates TSE:4538 with a GF Score™ of 51/100 and a GF Value™ of 円2,553.90 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fuso Pharmaceutical Industries's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.92%.

Fuso Pharmaceutical Industries  (TSE:4538) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fuso Pharmaceutical Industries ROCE % Related Terms

Fuso Pharmaceutical Industries ROCE % Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries ROCE % Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.85 5.45 4.30 -11.48 7.26

Fuso Pharmaceutical Industries Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 9.92 -34.86 6.60 7.92
TSE:4538
51GF Score
Fuso Pharmaceutical Industries Ltd TSE:4538
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuso Pharmaceutical Industries ROCE % Calculation

Fuso Pharmaceutical Industries's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=2766/( ( (81729 - 44131) + (90323 - 51684) )/ 2 )
=2766/( (37598+38639)/ 2 )
=2766/38118.5
=7.26 %

Fuso Pharmaceutical Industries's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=3036/( ( (85433 - 47428) + (90323 - 51684) )/ 2 )
=3036/( ( 38005 + 38639 )/ 2 )
=3036/38322
=7.92 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.92% mean?
Fuso Pharmaceutical Industries (TSE:4538) has a ROCE % of 7.92% as of Mar. 2026.
Is Fuso Pharmaceutical Industries' ROCE % too high?
Fuso Pharmaceutical Industries' current ROCE % is 7.92%. The Drug Manufacturers industry median ROCE % is 7.04. Fuso Pharmaceutical Industries' value of 7.92% is 12.5% above this industry median. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' ROCE % compare to ZTS and UTHR?
Fuso Pharmaceutical Industries' ROCE % of 7.92% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. Fuso Pharmaceutical Industries' value of 7.92% is 12.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fuso Pharmaceutical Industries's current ROCE % of 7.92% is 12.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuso Pharmaceutical Industries's current ROCE % is 7.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,553.90, compared to a current price of 円2,140.00 — trading 16.2% below its estimated fair value. The current ROCE % is 7.92% and 12.5% above the Drug Manufacturers industry median of 7.04. Fuso Pharmaceutical Industries' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current ROCE % is 7.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,140.00 is trading 16.2% below its estimated GF Value™ of 円2,553.90. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

  • ROCE %: 7.92%
  • GF Value™: 円2,553.90 vs. price of 円2,140.00 (16.2% below fair value)
  • GF Score™: 51/100 with 5 warning signs
  • Industry Position: 12.5% above the Drug Manufacturers median

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuso Pharmaceutical Industries Business Description

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
51GF Score

Get the complete analysis for TSE:4538

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,140.00
Price
円2,553.90
GF Value